Showing posts with label developing world bioethics. Show all posts
Showing posts with label developing world bioethics. Show all posts

Tuesday, November 25, 2014

On peer review


The debates among journal editors and other academics about the merits or otherwise of particular forms of peer review continue. A growing number of academics in the STEM subjects seem to think that post-publication peer review provides for higher quality control than the traditional post-submission pre-publication review. Their logic is that mistakes in manuscripts are less likely to be found during a process involving only a handful of reviewers. They furthermore argue that post-publication peer review will submit journal articles to scrutiny by a much larger number of readers. Methodological, statistical and other mistakes would almost certainly be found out in post-publication scrutiny with a higher likelihood simply due to the much larger number of expert reviewing (ie reading, analysing and commenting on) manuscripts post publication. It is difficult to argue with this contention, except to note that post publication peer review sites today suggest that only some of the manuscripts there receive such desirable academic community review. What does this proposal mean then for papers that are ignored altogether by peers. Will they still count as some kind of peer reviewed publications or are they just blog-equivalents? Who counts as a reviewer? Would the authors’ best friends be viable options? University administrators and appointments committees will want to know.

Of course, traditional peer review doesn’t preclude post-publication review. It happens that manuscripts that passed pre-publication review are eventually found to be seriously methodologically flawed. Many of those are withdrawn, but reluctant publishers and editors have also gained notoriety by leaving flawed manuscripts in the public domain without errata. Post-publication review depends to some extent on easy access to the manuscripts in question (Open Access being a bonus here), as well as the existence of sophisticated web-based moderated platforms permitting reader-peers to leave comments. It goes without saying that relentlessly profit-driven publishers of academic journals will be reluctant to invest in the staff necessary to manage this process.

I think, for humanities manuscripts, for the time being, pre-publication anonymous peer review remains the way to go. Anonymous peer review guarantees honest reviews from reviewers. Open review, whereby the reviewers and authors are disclosed to each other, will often prevent honest reviews, simply because reviewers inclined to be critical of a particular submission will be reluctant to burn their bridges by speaking frankly to the quality of a particular submission submitted by a close colleague or friend. Anonymous reviews are not in their own right a guarantee of quality. That’s where journal editors step in. They need to evaluate reviewers’ comments and decide what to do if reviewers’ verdicts vary significantly. You might be surprised to learn that this does not happen all that frequently. Reviewers almost always reach similar verdicts.

The challenge today is, of course, to find knowledgeable reviewers. I have lamented this problem here before. Senior colleagues are often reluctant to undertake this vital work. In fact, a few of them refuse to undertake reviews outright. That does not stop them from complaining bitterly if their manuscripts are, in their view, in the review process for an extraordinary amount of time. Perhaps we ought to institute a policy whereby as editors we would be well within our right to refuse to evaluate submissions from colleagues routinely unwilling to accept review requests.

Another issue arises when it comes to sourcing true peers to review particular content. Having now been an Editor of this journal and its companion journal for the last 15 years, I still struggle on occasion to find a suitable competent reviewer for a particular manuscript. It takes time, especially if the subject matter of a particular manuscript is highly specialised, to find the right peer reviewer. At this journal as well as its companion journal our standard operating procedure is that we as Editors have to find appropriate reviewers. We ask authors only in the rarest of exceptions to suggest possible reviewers to us. It turns out that choosing our own reviewers is a good idea, more so than we thought it is. Journals who ask authors for reviewer suggestions have been hit in fairly significant numbers by fake reviews, written under pseudonym by submitting authors, or by commercial outfits in the business of drafting fake reviews.[i] Post publication peer review publications should take note. You never stop learning when it comes to these matters, and sadly, nothing much surprises me any longer. The public or perish culture in today’s universities has clearly led to unreasonably pressures on academics, leading quite a few of us to stray from the right path.

Courtesy of the rise of open access on-line ‘journals’ we have reason to be weary of claims that the papers published in many such venues have been peer reviewed. As I write this, several incidents were reported where bogus papers have been accepted for publication by such outlets, for a processing fee, of course, delivered to the ‘editor’ via PayPal. Bound to be a classic is undoubtedly this one: The authors conjured up a fake paper with the title ‘Get me off your fucking mailing list’, directed at a SPAM Open Access outlet inviting contributions. Their paper was accepted, ostensibly after peer review.[ii] As any academic with a university affiliation will be able to testify to these days, the same outfits don’t discriminate as editors of more discerning journals would, in terms of competence to review particular academic outputs. A journalist employed at an Ottawa based newspaper reports that his submission of a fake article to a dodgy Open Access outfit ended up with him being now inundated with requests to review manuscripts he is utterly unqualified to review for said ‘publisher’.[iii] It is fair to say that on the odd occasion every editor will call on the wrong reviewer for a particular submission, but that is usually caught by the second or third reviewer, usually the invited reviewer declines. Apparently many pay-for-play Open Access publishing operations are primarily concerned about extracting author processing fees out of the submitting authors. That they can only achieve after they accept submitted content.

An issue remains apparently the Conflict of Interest declaration. There are all sorts of standards deployed by all sorts of publishing outfits, grant giving bodies and so on. Let me just say that I think reviewers would be well advised to err on the side of caution when they declare conflicts of interest. One good yardstick would be to ask yourself whether, if you were at the receiving end of your review, you would want to be advised (as an editor) of particular information that you are considering disclosing. Conflicts of interest could include knowledge of the authors’ identity, financial conflicts, but also that you might be an author harshly criticised or praised in the manuscript that you are reviewing. None of this would disqualify you per se from reviewing, but knowing about these potential conflicts would help editors to assess your comments more competently.
It is pretty obvious to anyone who has been in the business of publishing as an author or editor – or both – that anonymous peer review is far from perfect, and it is conceivable that new publishing platforms will eventually lead to the rise of better peer review processes. I for one am looking forward to those.


[i] Ferguson, C. 2014. It’s happened again: Journal cannot rule out possibility that author did his own peer review. Retraction Watch November 10. http://retractionwatch.com/2014/11/10/it-happened-again-journal-cannot-rule-out-possibility-author-did-his-own-peer-review/ [accessed November 25, 2014]

[ii] Bealls, J. 2014. Bogus Journal Accepts Profanity-Laced Anti-Spam Paper Scholarly Open Access November 20. http://scholarlyoa.com/2014/11/20/bogus-journal-accepts-profanity-laced-anti-spam-paper/ [accessed November 25, 2014]

[iii] Spears, Tom. 2014. How my fake science paper earned me a shot at an editor's job.  Ottawa Citizen. November 25. http://ottawacitizen.com/news/local-news/ok-no-problem-fakery-is-fine-at-bottom-feeding-journal [accessed November 25, 2014]

Thursday, November 14, 2013

Against the use of non-certified health 'remedies' in resource poor countries

My Editorial from the December issues of Developing World Bioethics.
Homeopathy organisations have taken to the skies to help sick people in resource poor countries as well as disaster zones. The thing about homeopathy is, of course, that there is zero evidence that homeopathic concoctions have any effect beyond that of other placebos.[1]Governments such as the UK's have clamped down on the quack therapy degrees that flourished for a good number of years in parts of its university sector. In 2007 a whopping 5 BSc degrees in homeopathy were offered; today there is none.[2]
While one could appreciate these homeopaths' good intentions, it is deeply unsettling that people without proper medical training use donations provided by their supporters to travel to developing countries and essentially apply their unproven concoctions on sick and dying people. During Haiti's recent cholera epidemic, on their own account they provided ‘remedies’ to cholera patients.[3] The term ‘remedy’ is probably carefully chosen by these people who show up in impoverished Haitian communities in medical-doctor-like white coats,[4] clearly giving the impression to the undereducated local populace that they are health care professionals. This masks to the uninitiated observer as well as to the local patients that their remedies are precisely that, concoctions that have no proven medicinal value. They are not medicines. The homeopathic emperor really is naked. I didn't say it first, but it is still true.
David Shaw, writing in the British Medical Journal, reports that ‘training’ programs have been set up that ‘train’ locals in homeopathy. He writes, ‘the creation of homeopathic pharmacies increases the likelihood that Haitians will not obtain effective treatments for future illnesses. Training 38 people as homeopaths simply compounds the unethical effects of Homeopaths Without Borders' presence in Haiti, as does the attempt at legitimisation represented by their attempt to obtain official licences.’[5]
A different example: other activists reportedly traveled from the USA to virulently anti-gay Jamaica to ‘heal’ gay Jamaicans and turn them into heterosexuals.[6] Vulnerable Jamaicans were subjected to treatments that are known not to work. What is by now illegal in many jurisdictions, namely offering and providing treatments for homosexuality, is now exported to resource-poor countries. Damage is predictably done to the psychological well-being of perfectly healthy gay Jamaicans.
It appears to be the case that the developing world has become a playground for the vaguely health-related activities of activists that have been thoroughly discredited in the wealthier and better educated parts of the world. These are shocking developments.
It is an interesting question how one should approach an ethical critique of these sorts of activities, namely of well-heeled Westerners abusing their privileged situation to inflict at best unproven medical concoctions and treatments on vulnerable populations in resource poor countries. If they were professionals (say in the Jamaican case if they were psychologists or psychiatrists, or in the Haitian case medical doctors or nurses) one could report them to their professional regulatory bodies. Unfortunately, these people are not professionals, hence appeals to ethical professionalism or professional bodies fail. Appeals to common sense are also likely to fail, because who other than a fanatic would want to travel to other countries to spread the word about concoctions that they know are not taken seriously by specialist professionals in their home countries?
Ethically, all that's left to say for the Haitian situation is that it is harmful to use such unproven concoctions and therapies on patients seeking help. It is also unacceptable to present oneself as a health care professional when one is not. For actual health care professionals providing homeopathic concoctions, the charge would be that they are acting unprofessionally by not providing standard, proven medical care. Cholera cannot be addressed with unproven homeopathic remedies. People will inevitably get hurt. For the Jamaican case, the harm to perfectly healthy people is again what is at issue. It will be distressing to these people both to undergo whatever ‘therapy’ is visited upon them, and it should be just as distressing to note that they failed, given the prevalent anti-gay sentiments in the country.
Harm is also done to impoverished communities by the fundraising activities of these organisations. Gullible donors will waste valuable financial resources that could go to actual sensible health care or development goals and that will instead be diverted toward the establishment and dissemination of quack therapies and treatments in resource poor environments.
To my mind governments in the West should police these activities in the same manner that they police the activities of sex tourists who travel to resource poor countries to exploit children. Equally, governments in Haiti, Jamaica and elsewhere should not permit their most vulnerable citizens to be abused by representatives of such organizations.

Sunday, July 21, 2013

Developing World Bioethics Special Issues on ARVs

Cover image for Vol. 13 Issue 2

Developing World Bioethics


Volume 13, Issue 2 Pages ii - iii, 57 - 104, August 2013

Special Issue: Anti-retrovirals for treatment and prevention – new ethical challenges

EDITORIAL

Anti-retrovirals for treatment and prevention – time for new paradigms in our response to the HIV/AIDS epidemic? (pages ii–iii)
Quarraisha Abdool Karim and Ronald Bayer
Article first published online: 18 JUL 2013 | DOI: 10.1111/dewb.12033

ARTICLES

Separate Goals, Converging Priorities: On the Ethics of Treatment as Prevention (pages 57–62)
Florian Ostmann and Carla Saenz
Article first published online: 25 JUN 2013 | DOI: 10.1111/dewb.12021
Ethics of ARV Based Prevention: Treatment-as-Prevention and PrEP (pages 63–69)
Bridget Haire and John M. Kaldor
Article first published online: 17 APR 2013 | DOI: 10.1111/dewb.12026
From modeling to morals: Imagining the future of HIV PREP in Lesotho (pages 70–78)
Nora J. Kenworthy and Nicola Bulled
Article first published online: 25 JUN 2013 | DOI: 10.1111/dewb.12029
Ethical Use of Antiretroviral Resources for HIV Prevention in Resource Poor Settings (pages 79–86)
Stuart Rennie
Article first published online: 31 MAY 2013 | DOI: 10.1111/dewb.12022
Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials: Examining PrEP (pages 87–94)
Bridget Haire, Morenike Oluwatoyin Folayan, Catherine Hankins, Jeremy Sugarman, Sheena McCormack, Gita Ramjee and Mitchell Warren
Article first published online: 31 MAY 2013 | DOI: 10.1111/dewb.12032
Ethical Tradeoffs in Trial Design: Case Study of an HPV Vaccine Trial in HIV-Infected Adolescent Girls in Lower Income Settings (pages 95–104)
J.C. Lindsey, S.K. Shah, G.K. Siberry, P. Jean-Philippe and M.J. Levin
Article first published online: 31 MAY 2013 | DOI: 10.1111/dewb.12028

Saturday, March 23, 2013

Are Bioethics and Developing World Bioethics institutionally racist?

The answer appears to be 'yes' if you believe a Letter to the Editor published recently by our colleagues at the Journal of Bioethical Inquiry. Three authors (one from India the other two from the USA and the Netherlands respectively -  ie two thirds from the global north, I'll get back to that!) decided one way to ascertain whether there's institutional bias toward the rich world's problems in bioethics journals would be to investigate the country location provided for the journals' editors as well as their editorial board members. They picked 14 journals, looked at their overall number of editorial board members and divided them into groups based on the Human Development Index into Very High and High, Medium and Low. To no one's surprise they discovered that the vast majority of Editorial Board members hail from Very High and High HDI countries. You might wish to note that High HDI includes countries such as Jamaica, Malaysia, Grenada, Brazil, Iran and so on and so forth. The current list is here. So, by lumping countries such as Germany and Jamaica into one category (ie by lumping together Very High and High HDI) the authors of the letter have arguably created the particular outcome they needed to mount their criticism, namely the underrepresentation of bioethicists from developing countries on bioethics journals editorial boards. They discovered that 95% of editorial board members hail from these countries. These countries, of course, include countries as far apart in terms of development as are Germany and Libya.

Surprisingly this question begging bean counting activity must have passed peer review at the Journal of Bioethics Inquiry. Well, or it passed the editorial judgment of whoever is currently in charge at that journal. 

Now, fair enough, it is reasonable to be concerned about bioethics focus on the - often times decadent - problems of folks in the global north while ignoring more serious issues confronting people in the global south. I certainly feel passionately about this and have done my best during my years as one of the Editors of Bioethics and as one of the Founding Editors of Developing World Bioethics to remedy this situation. Let me show you how this pans out in the Letter writers analysis. I mentioned already that they're lumping - unreasonably - together folks from Germany and Jamaica or Australia and Dominica to generate the scandal they are keen on exposing. Bioethics is listed here as a journal with zero representatives from medium and low HDI. Brilliant insight. Here is the context the Letter writers ignored - were too busy investigating. 

On my initiative, more than a decade ago, while I was working full-time as an academic in South Africa, we made a considered decision to 'sacrifice' some of the Bioethics print real estate (ie the number of print issues we could produce in a given year) by starting a companion journal dedicated exclusively to developing world issues, and so Developing World Bioethics was born. Its distribution is identical to that of Bioethics, so wherever Bioethics is available in a personal or institutional subscription, there is also Developing World Bioethics. You could argue now that that surely was just a means to shunt aside issues affecting the global south, but incidentally the success of Developing World Bioethics in competitive journal impact rankings (where it does better than many mainstream bioethics journals) suggests otherwise. Criticizing Bioethics then for not having editorial board members from medium to low-income HDI countries completely misses the point of this arrangement. It constitutes unfair and uninformed criticism. Incidentally, 2/3rds of the Letter's authors hail from countries of the global north. Their own logic applied to their own letter would suggest that that somehow isn't a good thing. 

A more serious omission by the authors is their decision not to undertake actual serious qualitative research.  After all, the Letter writers have not even bothered to undertake an actual content analysis to investigate (and demonstrate) that the problem they are concerned about exists. Instead they say this, 'Scanning 4,029 research articles in nine bioethics journals, Borry, Schotsmans, and Dierickx (2005) found that developing country scholars contributed fewer than 4 percent of publications (the other 96 percent coming from authors working in developed countries). It is no surprise, then, that bioethics pays more attention to esoteric ethical problems facing wealthy nations than it does to issues such as poverty, hunger, and health inequities that are global in nature.'

You might wish to note that the study they cite ignored Developing World Bioethics. There's something amusing about scholars trying really hard to show how badly the global south is done by by mainstream bioethics, yet they have to resort to unnecessary acts of omissions, such as ignoring journals dedicated exclusively to this issue. They also ignore something else: many journals focusing strongly on these issues (in China, in Brazil, in Iran and so on and so fourth) do not feature on their list.  Why should non-English speaking academics working in the global south submit content to English language journals that are not widely read in their home countries? Are they doing wrong, in the eyes of our Letter writers, when they focus on journals in their mother tongue that are actually locally read by their fellow country men and women? 

My bone of contention with the authors of this Letter (and the Editors of the journal that published it) is that the research that it is based on is shoddy at best; that even if it wasn't as shoddy as it is it would still not have been able to show what needs to be shown, namely that the absence of editorial board members from the countries in question is the cause of bioethics lack of focus on issues the Letter writers are rightly concerned about.

Arguably today more content than ever before is produced by bioethicists on these issues. Perhaps not enough, but since Developing World Bioethics has come into being a lot has changed for the better. Journals such as the Journal of Global Ethics, Metaphilosophy, Public Health Ethics and others continue to produce high-quality outputs on the issues the Letter writers are concerned about. 

Friday, March 22, 2013

Open Access Issue: Special Issue: Field workers at the interface between research institutions and local communities

Cover image for Vol. 13 Issue 1

Developing World Bioethics

© Blackwell Publishing Ltd

Volume 13, Issue 1 Pages ii - iv, 1 - 56, April 2013

Special Issue: Field workers at the interface between research institutions and local communities
The latest issue of Developing World Bioethics is available on Wiley Online Library

EDITORIAL

Field Workers at the Interface (pages ii–iv)
Sassy Molyneux, Dorcas Kamuya, Philister Adhiambo Madiega, Tracey Chantler, Vibian Angwenyi and P. Wenzel Geissler
Article first published online: 22 MAR 2013 | DOI: 10.1111/dewb.12027

ARTICLES

Evolving Friendships and Shifting Ethical Dilemmas: Fieldworkers’ Experiences in a Short Term Community Based Study in Kenya (pages 1–9)
Dorcas M. Kamuya, Sally J. Theobald, Patrick K. Munywoki, Dorothy Koech, Wenzel P. Geissler and Sassy C. Molyneux
Article first published online: 21 FEB 2013 | DOI: 10.1111/dewb.12009
Engaging Communities to Strengthen Research Ethics in Low-Income Settings: Selection and Perceptions of Members of a Network of Representatives in Coastal Kenya (pages 10–20)
Dorcas M. Kamuya, Vicki Marsh, Francis K. Kombe, P. Wenzel Geissler and Sassy C. Molyneux
Article first published online: 21 FEB 2013 | DOI: 10.1111/dewb.12014
‘She's My Sister-In-Law, My Visitor, My Friend’ – Challenges of Staff Identity in Home Follow-Up in an HIV Trial in Western Kenya (pages 21–29)
Philister Adhiambo Madiega, Gemma Jones, Ruth Jane Prince and Paul Wenzel Geissler
Article first published online: 22 MAR 2013 | DOI: 10.1111/dewb.12019
Ethical Challenges that Arise at the Community Interface of Health Research: Village Reporters’ Experiences in Western Kenya (pages 30–37)
Tracey Chantler, Faith Otewa, Peter Onyango, Ben Okoth, Frank Odhiambo, Michael Parker and Paul Wenzel Geissler
Article first published online: 22 MAR 2013 | DOI: 10.1111/dewb.12023
Working with Community Health Workers as ‘Volunteers’ in a Vaccine Trial: Practical and Ethical Experiences and Implications (pages 38–47)
Vibian Angwenyi, Dorcas Kamuya, Dorothy Mwachiro, Vicki Marsh, Patricia Njuguna and Sassy Molyneux
Article first published online: 22 MAR 2013 | DOI: 10.1111/dewb.12015
Feedback of Research Findings for Vaccine Trials: Experiences from Two Malaria Vaccine Trials Involving Healthy Children on the Kenyan Coast (pages 48–56)
Caroline Gikonyo, Dorcas Kamuya, Bibi Mbete, Patricia Njuguna, Ally Olotu, Philip Bejon, Vicki Marsh and Sassy Molyneux
Article first published online: 21 FEB 2013 | DOI: 10.1111/dewb.12010

Friday, May 25, 2012

Sabbatical Projects

I meant to write this awhile ago, but haven't had a chance to do so. These days I am pretty busy working on various book projects that involve fairly heavy writing as well as editing. I'm hoping, when my sabbatical is over in a year's time, I might have three books to show for the time spent away from university. So, here's the plan. I'm writing with Russell Blackford 50 Great Myths About Atheism. I guess it's fair to say that we are only a few weeks away from completing the manuscript. Then I'm producing with Helga Kuhse and Peter Singer the 3rd edition of the bioethics text book Bioethics: An Anthology. We hope to be done with this project by the end of this year. Last but not least, come August I will start writing in all earnest for a joint project with Christopher Lowry, a book called Global Health Ethics. All of these will be out with Wiley-Blackwell.

Well, other than these projects, I do continue editing both the journals Bioethics as well as Developing World Bioethics, with Ruth Chadwick and Debora Diniz, respectively. There's also a few other articles promised to editors of anthologies and bioethics journals that I am trying to complete. Yep, that's about it. It's gonna be a very busy time. It's interesting that fellow academics' first question, when they hear that you're going on a sabbatical, is 'where are you going?', when really they might as well ask, 'what will you be doing?'. Anyhow, I'm trying to travel as little as is feasible in order to get on with the task of completing these projects.

Sunday, February 19, 2012

Ethical considerations in the use of anti-retrovirals for HIV prevention



Call for Papers

Evidence-based approaches to reducing sexual transmission of HIV has remained a major challenge in responding to the HIV pandemic.  The past 18 months has witnessed a substantial shift in this landscape.  Controlled trials have demonstrated that the treatment of individuals with HIV infection reduces the risk of viral transmission to uninfected sexual partners (treatment as prevention).  Additional evidence suggests the possibility of providing anti-retroviral medications to uninfected individuals may reduce the risk of acquiring HIV infection from sexual partners (PrEP— Pre-Exposure Prophylaxis).

In view of scarce resources, there will inevitably be a need to prioritize who will get anti-retroviral drugs; those who are sick, those who can transmit HIV, those at risk for acquiring HIV. Research that focuses on the balance between efficiency and equity will be involved.  Ethical frameworks for guiding decision-making at the clinical level as well as the macro social policy level will be essential.

Among the questions that will need to be discussed are:  

i.                    What rights claims can uninfected persons make for access to ARVs for prophylactic purposes when millions across the globe are dying from AIDS because they cannot access ARV treatment? 
ii.                   What moral claims can justify the provision of ARV therapy to those who do not yet clinically require treatment as a way of reducing the risks of HIV transmission?
iii.                  What normative issues are raised in making the determination that there is sufficient evidence to demonstrate the effectiveness of either PrEP or Treatment for Prevention? 
iv.                 How should the social and biological vulnerability of women to HIV infection inform discussion about the allocations of resources for either PrEP or treatment as prevention? 
v.                  If there is a risk that PrEP will increase the risk of drug resistance and compromise treatment options for those already infected, what ethical questions must be confronted? 
vi.                 What conceptions of procedural fairness and inclusiveness should shape decision making processes about these allocation decisions?
vii.                How should current research findings inform the ethics of trial design?
viii.               Given current evidence what moral issues involving the protection of research subjects should be considered in determining the extent of ancillary services and care that should be provided in prevention trials? 

This issue of Developing World Bioethics will be guest edited by Ronald Bayer (email: rb8@mail.cumc.columbia.edu) and Quarraisha Abdool Karim (email: abdoolq2@ukzn.ac.za), Mailman School of Public Health, Columbia University, New York, NY  10032  USA.

Deadline for submissions: 31 July 2012

Sunday, June 26, 2011

News from BIOETHICS and DEVELOPING WORLD BIOETHICS

The journals
We got our annual report from our publisher a few days ago. Much of the stuff there is confidential, of course (and would likely bore you, too). However, there's bits and pieces of statistics that you might find interesting. In case you don't know the journals, or don't know them well, Bioethics is now in its 25th year of existence. It publishes 9 issues per calendar year. Developing World Bioethics is now in its 11th year of existence. It publishes 3 issues per calendar year. The journals come in a package, so what it boils down to is a monthly publication schedule. Bioethics is also the official publication of the International Association of Bioethics. This essentially entails us publishing every two years a special issue with the best contents form the IAB Congress, as well as us offering deeply discounted subscriptions to paid-up members of the IAB. We continue to sponsor events held during the IAB Congress every two years. Recently we have also provided sponsorship to a postgraduate bioethics conference held in the UK.

Our reach and academic success
We have been able to increase the reach of both journals quite significantly in 2010. The journals are available in about 3,500 university libraries by regular subscriptions. A further 6,000 libraries in developing countries have access to the journal at this point in time. I should like to add that this - to my mind - puts to rest claims about the unavailability of our academic content in the developing world due to high subscription fees. A further 5,200 libraries worldwide are able to access our content a year after it has been published.  So, in total, slightly less than 15,000 libraries across the globe provide access to our content.

This wide availability has also resulted in another significant boost to article downloads from our journals. In total about 250,000 articles from both journals were downloaded in 2010.

The European Science Foundation has given Bioethics the highest ranking available in the philosophy category.

Our upcoming content
Ruth Chadwick, Bioethics' other Editor, and I have lined up a whole range of interesting special issues over the next few years, covering topics all the way from synthetic organisms to ageing.  In case you're one of our readers, give us a shout with suggestions for special issue topics. We are always keen to hear from you!

Publication ethics
On the publication ethics fronts, we have introduced extensive regulations on authorship and conflict of interest matters that we hope will keep us out of the firing line on these issues for the foreseeable future.

Editorial board, bias and peer review
Last but not least, following our most recent review, invitations will be going out to a few academics to join our Editorial Board. Funny enough, that should also put to rest any suspicions that you might have with regard to editorial bias. Of the new members on the Editorial Board of the journal two are colleagues with whom I had quite serious professional conflict in the distant and in the very recent past, respectively. None of that made any difference to our decision to appoint to our Editorial Board. What matters crucially are competence and reliability. Reliability of reviewers is becoming sadly an ever bigger challenge. You would expect that academics who themselves publish academic contents in academic journals would be willing to review colleagues' academic content (the golden rule and all that jazz). The truth is though that that is becoming ever more difficult. All too often the most experienced peer reviewers decline and editors have to move lower down the list of experienced and knowledgable academics. The same authors, in other words, who would be all too keen to have their paper reviewed by a top academic like themselves are all too often not prepared to provide a similar courtesy in return when they are being asked to review academic content. This is quite disappointing, but equally, until university administrations and research funders give credit to academics for providing such services to the academic community, it is understandable that individual academics vote for working on their own paper rather than reviewing someone else's paper. All I can say is that some academics are paradigms of how a professional should act in this context and others are paradigms of the how-not-to. The former probably do not know how grateful we really are to them, as journal editors, for their services.

Sunday, June 20, 2010

Bioethics and Developing World Bioethics show improved impact factors

As you probably know, I am a co-editor of two peer reviewed international journals called Bioethics and Developing World Bioethics. Each year a commercial Canadian outfit called ISI (owned by Thomson Reuters) delivers its verdict on journals' impact (often confused with quality by journalists, academics and university administrators).

Publishers invariably get excited about their journals as good impact factors mean 'better' journals mean better marketing opportunities mean more money. There is plenty of evidence to go around that the impact factor is highly unreliable (in fact, ISI failed to reproduce, on request, its own impact factors in several test cases). Still, much like donors, students and government funders take notoriously nonsensical university rankings as their gospel, academics use high-ranked journals as preferred outlets and so this stuff becomes a self-fulfilling prophecy. In many universities academics are receiving bonuses for publishing in high-ranking journals. The idea is that a high-ranking journal is difficult to get into and voila, another quality standard is born. Duly, once you're high-ranking individual national science agencies begin dumping A's and similar rankings on you. More incentives for academics working under the influence of these agencies to publish in 'A' ranked journals. Of course, this all translates into creating self-fulfilling prophecies. It seems it hasn't occurred to anyone yet that a 'journal' publishing one article per year that gets cited a lot would have a stratospheric impact factor, and it would be difficult to get published in. So that useless journal with its one article per volume would be very 'prestigious' on the relevant counts.

This year ISI has increased the number of non-English journals it ranks, but there's an inherent bias in its ranking of these journals as ISI has no way to actually measure the citations of these journals reliably. As a result of the new inclusion policies these journals rank consistently low and assist in artificially boosting the group ranking of English language journals. For instance, a little-known English language bioethics journal that normally would have been safely ensconded on the bottom of the ranking is now being surpassed in the race to the bottom by Italian and German language bioethics journals.

Anyhow, this is just to report that Bioethics increased its impact factor to 1.136 while Developing World Bioethics, in its first entry scored a nice 1.256. Both journals managed to 'beat' quite a few very well-known competing publications. So all is good on the journals front. In a list of 34 journals in the 'ethics' category we made it to ranks 7 and 9 respectively,

Ethical Progress on the Abortion Care Frontiers on the African Continent

The Supreme Court of the United States of America has overridden 50 years of legal precedent and reversed constitutional protections [i] fo...